<DOC>
	<DOCNO>NCT00157963</DOCNO>
	<brief_summary>An efficacy safety study hydrochlorothiazide ( + ) losartan potassium compare amlodipine week 12 Korean patient essential hypertension</brief_summary>
	<brief_title>Hydrochlorothiazide ( + ) Losartan Potassium vs. Amlodipine Comparative Study ( 0954A-314 )</brief_title>
	<detailed_description />
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients age 20 70 75 essential hypertension SiDBP 90 ~ 114mmHg V1 &amp; V2 Patient know suspect secondary hypertension Patient history malignant hypertension ( SiSBP &gt; 210mmHg ) Individuals know sensitivity intolerance HCTZ AIIAs , sulfonamidederived drug . Patient show significant abnormal laboratory evaluation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>